Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis

The effect of delay in time to adjuvant chemotherapy (TTAC) on survival in breast cancer (BC): A systematic review and meta-analysis.

(2017) J. J. Biagi et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer

(2013) Z. Z. Nurgalieva et al.   MEDICAL ONCOLOGY

Effect of Large Tumor Size on Cancer-Specific Mortality in Node-Negative Breast Cancer

(2012) Ke-Da Yu et al.   MAYO CLINIC PROCEEDINGS

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer

(2011) James J. Biagi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vitamin B6and Risk of Colorectal Cancer

(2010) Susanna C. Larsson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Delays in Adjuvant Chemotherapy Treatment Among Patients With Breast Cancer Are More Likely in African American and Hispanic Populations: A National Cohort Study 2004-2006

(2010) Stacey A. Fedewa et al.   JOURNAL OF CLINICAL ONCOLOGY

Optimal timing of adjuvant treatment in patients with early breast cancer

(2010) Necati Alkis et al.   MEDICAL ONCOLOGY

A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer

(2009) Ke-Da Yu et al.   FASEB JOURNAL